Sigma Planning Corp Oncternal Therapeutics, Inc. Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	BUY	$1.37 - $2.43 $685 - $1,215	500 Added 2.56%	20,025 $28,000
Q4 2021 Feb 02, 2022	BUY	$2.27 - $4.39 $16,684 - $32,266	7,350 Added 60.37%	19,525 $44,000
Q3 2021 Oct 28, 2021	SELL	$3.37 - $4.76 $1,627 - $2,299	-483 Reduced 3.82%	12,175 $51,000
Q2 2021 Aug 13, 2021	BUY	$4.75 - $9.39 $60,125 - $118,858	12,658 New	12,658 $60,000

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $29.4M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.